EA201001861A1 - С-замещенные в кольце прегн-4-ен-21,17-карболактоны, и фармацевтические продукты, содержащие их - Google Patents

С-замещенные в кольце прегн-4-ен-21,17-карболактоны, и фармацевтические продукты, содержащие их

Info

Publication number
EA201001861A1
EA201001861A1 EA201001861A EA201001861A EA201001861A1 EA 201001861 A1 EA201001861 A1 EA 201001861A1 EA 201001861 A EA201001861 A EA 201001861A EA 201001861 A EA201001861 A EA 201001861A EA 201001861 A1 EA201001861 A1 EA 201001861A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pregn
substituted
ring
carbolactons
products containing
Prior art date
Application number
EA201001861A
Other languages
English (en)
Other versions
EA017570B1 (ru
Inventor
Свен Ринг
Рольф Больманн
Йоахим Кунке
Лудвиг Цорн
Штеффен Борден
Катя Прелле
Original Assignee
Байер Шеринг Фарма Акциенгезельшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41061273&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201001861(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Байер Шеринг Фарма Акциенгезельшафт filed Critical Байер Шеринг Фарма Акциенгезельшафт
Publication of EA201001861A1 publication Critical patent/EA201001861A1/ru
Publication of EA017570B1 publication Critical patent/EA017570B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Изобретение касается С-замещенных в кольце прегн-4-ен-21,17-карболактонов общей формулы Iв которой Rпредставляет собой α- или β-метилен, и Rпредставляет собой атом водорода, и Rпредставляет собой атом брома, хлора или фтора, или Rи Rвместе означают связь. Новые соединения представляют собой антиминералокортикоидные прогестероны.
EA201001861A 2008-06-02 2009-05-26 С-замещенные в кольце прегн-4-ен-21,17-карболактоны и фармацевтические продукты, содержащие их EA017570B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008026793A DE102008026793A1 (de) 2008-06-02 2008-06-02 C-Ring-substituierte Pregn-4-en-21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate
PCT/EP2009/003716 WO2009146811A1 (de) 2008-06-02 2009-05-26 C-ring-substituierte pregn-4-en-21,17-carbolactone, sowie diese enthaltende pharmazeutische präparate

Publications (2)

Publication Number Publication Date
EA201001861A1 true EA201001861A1 (ru) 2011-08-30
EA017570B1 EA017570B1 (ru) 2013-01-30

Family

ID=41061273

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201001861A EA017570B1 (ru) 2008-06-02 2009-05-26 С-замещенные в кольце прегн-4-ен-21,17-карболактоны и фармацевтические продукты, содержащие их

Country Status (29)

Country Link
US (1) US20110130371A1 (ru)
EP (1) EP2297177B1 (ru)
JP (1) JP2012528075A (ru)
KR (1) KR20110020240A (ru)
CN (1) CN102046646B (ru)
AR (1) AR071984A1 (ru)
AU (1) AU2009254266A1 (ru)
BR (1) BRPI0913401A2 (ru)
CA (1) CA2726855A1 (ru)
CL (1) CL2009001342A1 (ru)
CO (1) CO6321132A2 (ru)
CR (1) CR11821A (ru)
DE (1) DE102008026793A1 (ru)
DO (1) DOP2010000372A (ru)
EA (1) EA017570B1 (ru)
EC (1) ECSP10010652A (ru)
ES (1) ES2389237T3 (ru)
HK (1) HK1156954A1 (ru)
HN (1) HN2010002548A (ru)
IL (1) IL209371A0 (ru)
MA (1) MA32321B1 (ru)
MX (1) MX2010013233A (ru)
NZ (1) NZ589593A (ru)
PE (1) PE20100154A1 (ru)
SV (1) SV2010003748A (ru)
TW (1) TW201000106A (ru)
UY (1) UY31859A (ru)
WO (1) WO2009146811A1 (ru)
ZA (1) ZA201009097B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012004248A1 (de) 2010-07-08 2012-01-12 Bayer Pharma Aktiengesellschaft MIKROBIOLOGISCHES VERFAHREN ZUR HERSTELLUNG VON 11α-HYDROXY-DROSPIRENON
WO2012059594A1 (en) 2010-11-04 2012-05-10 Bayer Pharma Aktiengesellschaft Mineralcorticoid receptor antagonists for the treatment of corticoid-induced obesity
CN102876582B (zh) * 2011-07-15 2015-01-07 复旦大学 金龟子绿僵菌突变株及其在甾体化合物羟化反应中的应用
WO2015055789A1 (en) * 2013-10-17 2015-04-23 Bayer Pharma Aktiengesellschaft INTRAVAGINAL USE OF 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, INTRAVAGINAL RINGS COMPRISING 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, AND USE THEREOF IN CONTRACEPTION
CN105779553B (zh) * 2014-12-15 2020-10-27 天津金耀集团有限公司 新月弯孢霉和节杆菌联合发酵制备11β-羟基-1,4-二烯-3,20-二酮甾体化合物
CN105779555B (zh) * 2014-12-15 2021-02-02 天津金耀集团有限公司 犁头霉和节杆菌联合发酵制备11β-羟基-1,4-二烯-3,20-二酮甾体化合物
CN104862323B (zh) * 2015-06-02 2018-01-16 中国农业科学院生物技术研究所 修饰苯二酚类化合物的羟化酶基因

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3092628A (en) * 1959-05-29 1963-06-04 Merck & Co Inc Aldosterone antagonists
US3095412A (en) * 1961-12-19 1963-06-25 Searle & Co 9alpha, 11alpha-epoxy and 11beta-chloro-9alpha-hydroxy 17alpha-(2-carboxyethyl)-17beta-hydroxyandrost-4-en-3-one gamma-lactones and delta1 and delta6 analogs
DE1183500B (de) 1962-10-12 1964-12-17 Schering Ag Verfahren zur Herstellung von alpha, beta-Methylenketonen der Steroidreihe
US3539558A (en) * 1968-08-09 1970-11-10 Searle & Co 3 - oxygenated 3 - (9alpha,11beta - dichloro-17beta- hydroxyandrosten - 17alpha-yl)propionic acid gamma-lactones and congeners
DE2453823C2 (de) * 1974-11-11 1984-08-09 Schering AG, 1000 Berlin und 4709 Bergkamen 11β,17α-Dihydroxy-15α,16α-methylen-1,4-pregnadien-3,20-dion
DE2922500A1 (de) 1979-05-31 1980-12-04 Schering Ag 6 beta .7 beta
FI77669C (fi) * 1983-04-13 1989-04-10 Ciba Geigy Ag 20-spiroxaner och analoger, som innehaoller en oeppen ring e, foerfarande foer deras framstaellning samt dessa innehaollande farmaceutiska preparat.
HUP0402466A2 (en) * 2004-11-30 2006-07-28 Richter Gedeon Vegyeszet Industrial process for preparing 17-hydroxy-6-betha, 7-betha, 15-betha, 16-betha-bis-methylene-3-oxo-17-alpha-pregn-4-ene-21-carboxylic acid gamma lacton and the main, intermediates of the process
DE102004063864A1 (de) 2004-12-30 2006-07-13 Schering Ag 18-Methyl-19-nor-17-pregn-4-en21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate
ATE403668T1 (de) * 2005-07-21 2008-08-15 Bayer Schering Pharma Ag Verfahren zur herstellung von 3-oxo-pregn-4-en-21,17-carbolactonen durch die metallfreie oxidation von 17-(3-hydroxypropyl)-3,17- dihydroxyandrostanen
WO2007025780A2 (en) * 2005-09-02 2007-03-08 Recordati Ireland Limited Aldosterone receptor antagonists
DE102006030416A1 (de) 2006-06-29 2008-01-03 Bayer Schering Pharma Ag 18-Methyl-19-nor-androst-4-en-17,17-spiroether (18-Methyl-19-nor-20-spirox-4-en-3-one) sowie diese enthaltende pharmazeutische Präparate
ITMI20061802A1 (it) * 2006-09-22 2008-03-23 Antibioticos Spa Epossidazione di 17-oxo-15,16-metilen steroidi con ilidi di solfossonio

Also Published As

Publication number Publication date
HK1156954A1 (ru) 2012-06-22
AR071984A1 (es) 2010-07-28
CL2009001342A1 (es) 2010-05-28
HN2010002548A (es) 2012-08-27
MA32321B1 (fr) 2011-05-02
CA2726855A1 (en) 2009-12-10
CR11821A (es) 2011-02-04
US20110130371A1 (en) 2011-06-02
CN102046646B (zh) 2013-03-27
EA017570B1 (ru) 2013-01-30
TW201000106A (en) 2010-01-01
SV2010003748A (es) 2011-04-06
CN102046646A (zh) 2011-05-04
EP2297177A1 (de) 2011-03-23
CO6321132A2 (es) 2011-09-20
PE20100154A1 (es) 2010-03-20
AU2009254266A1 (en) 2009-12-10
UY31859A (es) 2010-01-05
MX2010013233A (es) 2010-12-21
DE102008026793A1 (de) 2009-12-03
JP2012528075A (ja) 2012-11-12
WO2009146811A1 (de) 2009-12-10
IL209371A0 (en) 2011-01-31
BRPI0913401A2 (pt) 2015-11-24
KR20110020240A (ko) 2011-03-02
ECSP10010652A (es) 2011-01-31
ZA201009097B (en) 2012-05-01
NZ589593A (en) 2012-04-27
ES2389237T3 (es) 2012-10-24
EP2297177B1 (de) 2012-06-20
DOP2010000372A (es) 2010-12-31

Similar Documents

Publication Publication Date Title
PH12015500263A1 (en) New bicyclic derivatives
EA201001861A1 (ru) С-замещенные в кольце прегн-4-ен-21,17-карболактоны, и фармацевтические продукты, содержащие их
CR20140229A (es) Nuevos derivados bicíclicos de dihidroisoquinolin-1-ona
PH12014502697B1 (en) New diazaspirocycloalkane and azaspirocycloalkane
UY33735A (es) Compuestos antivirales
EA201101620A1 (ru) Ингибиторы репликации вируса иммунодефицита человека
RS54386B1 (en) ANTIVIRAL UNITS
MY181898A (en) Heterocyclic compounds and uses thereof
CR20130045A (es) Compuestos terapéuticos
MY169043A (en) New dihydroquinoline-2-one derivatives
EA201000777A1 (ru) Ингибиторы репликации вируса иммунодефицита человека
EA201070786A1 (ru) Бензофуропиримидиноны
MX341133B (es) Compuestos y metodos para la inhibición de hdac.
UA108101C2 (xx) Похідні n3-заміщених n1-сульфоніл-5-фторпіримідинонів
EA201290632A1 (ru) Производные бетулина
MX2009013354A (es) Compuestos de triarilo y composiciones que los contienen.
MX2014014531A (es) Derivados de aminoquinazolina y piridopirimidina.
MY169267A (en) New aryl-quinoline derivatives
EA201270256A1 (ru) Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида
UA106889C2 (uk) Похідні n1-ацил-5-фторпіримідинону
EA201270255A1 (ru) 5-фтор-2-оксопиримидин-1(2h)-карбоксилатные производные
EA201101675A1 (ru) Спироэпоксиды как промежуточные продукты синтеза
TN2012000105A1 (en) Spirolactam derivatives and uses of same
WO2012154879A3 (en) Autophagy inhibitors
GB201020397D0 (en) Compounds

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU